Published in Ther Adv Endocrinol Metab on April 01, 2012
Paraneoplastic syndromes in olfactory neuroblastoma. Contemp Oncol (Pozn) (2015) 0.90
Hyponatremia secondary to the syndrome of inappropriate secretion of antidiuretic hormone (SIADH): therapeutic decision-making in real-life cases. Clin Kidney J (2013) 0.83
Evidence for the use of demeclocycline in the treatment of hyponatraemia secondary to SIADH: a systematic review. Int J Clin Pract (2015) 0.80
The Trafficking of the Water Channel Aquaporin-2 in Renal Principal Cells-a Potential Target for Pharmacological Intervention in Cardiovascular Diseases. Front Pharmacol (2016) 0.78
Managing severe peripartum hyponatraemia: A case report. Obstet Med (2014) 0.75
Hyponatremia in the intensive care unit: How to avoid a Zugzwang situation? Ann Intensive Care (2015) 0.75
A case report on acute severe hyponatraemia following parathyroid surgery for primary hyperparathyroidism-A rare but life threatening complication. Int J Surg Case Rep (2016) 0.75
Hyponatremia - A rare complication of Gitelman's syndrome. Indian J Nephrol (2017) 0.75
Syndrome of inappropriate antidiuretic hormone secretion due to excessive intake of memantine. Neurol Sci (2015) 0.75
Hyponatremia. N Engl J Med (2000) 11.31
Tolvaptan, a selective oral vasopressin V2-receptor antagonist, for hyponatremia. N Engl J Med (2006) 10.63
Clinical practice. The syndrome of inappropriate antidiuresis. N Engl J Med (2007) 6.97
Hyponatremia and mortality among patients on the liver-transplant waiting list. N Engl J Med (2008) 6.67
A syndrome of renal sodium loss and hyponatremia probably resulting from inappropriate secretion of antidiuretic hormone. Am J Med (1957) 6.11
Mild chronic hyponatremia is associated with falls, unsteadiness, and attention deficits. Am J Med (2006) 4.33
Nephrogenic syndrome of inappropriate antidiuresis. N Engl J Med (2005) 3.83
Mortality after hospitalization with mild, moderate, and severe hyponatremia. Am J Med (2009) 3.76
Oral tolvaptan is safe and effective in chronic hyponatremia. J Am Soc Nephrol (2010) 3.64
Incidence and prevalence of hyponatremia. Am J Med (2006) 3.61
Persistent ascites and low serum sodium identify patients with cirrhosis and low MELD scores who are at high risk for early death. Hepatology (2004) 3.45
Osmotic demyelination syndrome following correction of hyponatremia. N Engl J Med (1986) 3.44
Mild hyponatremia and risk of fracture in the ambulatory elderly. QJM (2008) 3.28
Hyponatremia treatment guidelines 2007: expert panel recommendations. Am J Med (2007) 3.22
Hyponatremia independent of osteoporosis is associated with fracture occurrence. Clin J Am Soc Nephrol (2010) 3.13
Hyponatremia: a prospective analysis of its epidemiology and the pathogenetic role of vasopressin. Ann Intern Med (1985) 2.82
Treatment of symptomatic hyponatremia and its relation to brain damage. A prospective study. N Engl J Med (1987) 2.73
Prognostic importance of serum sodium concentration and its modification by converting-enzyme inhibition in patients with severe chronic heart failure. Circulation (1986) 2.69
Impact of hospital-associated hyponatremia on selected outcomes. Arch Intern Med (2010) 2.67
Hyponatremia and inappropriate secretion of vasopressin (antidiuretic hormone) in patients with hypopituitarism. N Engl J Med (1989) 2.66
Hyponatremia: evaluating the correction factor for hyperglycemia. Am J Med (1999) 2.30
Hypertonic saline for hyponatremia: risk of inadvertent overcorrection. Clin J Am Soc Nephrol (2007) 2.29
Neurologic sequelae after treatment of severe hyponatremia: a multicenter perspective. J Am Soc Nephrol (1994) 2.28
Rapid correction of hyponatremia in the syndrome of inappropriate secretion of antidiuretic hormone. An alternative treatment to hypertonic saline. Ann Intern Med (1973) 2.04
Superiority of demeclocycline over lithium in the treatment of chronic syndrome of inappropriate secretion of antidiuretic hormone. N Engl J Med (1978) 1.98
Hyponatremia-induced osteoporosis. J Bone Miner Res (2010) 1.95
Value of fractional uric acid excretion in differential diagnosis of hyponatremic patients on diuretics. J Clin Endocrinol Metab (2008) 1.86
Association between rise in serum sodium and central pontine myelinolysis. Ann Neurol (1982) 1.85
Severe hyponatraemia: complications and treatment. QJM (1995) 1.71
Effects of satavaptan, a selective vasopressin V(2) receptor antagonist, on ascites and serum sodium in cirrhosis with hyponatremia: a randomized trial. Hepatology (2008) 1.70
Characteristics and mortality of severe hyponatraemia--a hospital-based study. Clin Endocrinol (Oxf) (2006) 1.66
Intravenous conivaptan for the treatment of hyponatraemia caused by the syndrome of inappropriate secretion of antidiuretic hormone in hospitalized patients: a single-centre experience. Nephrol Dial Transplant (2010) 1.63
Development of severe hyponatraemia in hospitalized patients: treatment-related risk factors and inadequate management. Nephrol Dial Transplant (2005) 1.61
Severe symptomatic hyponatremia: treatment and outcome. A study of 64 cases. Ann Intern Med (1987) 1.58
Medical costs of abnormal serum sodium levels. J Am Soc Nephrol (2008) 1.56
Assessment of the efficacy and safety of intravenous conivaptan in euvolemic and hypervolemic hyponatremia. Am J Nephrol (2007) 1.48
Regulation of arginine vasopressin in the syndrome of inappropriate antidiuresis. Am J Med (2006) 1.41
Efficacy and safety of oral conivaptan: a V1A/V2 vasopressin receptor antagonist, assessed in a randomized, placebo-controlled trial in patients with euvolemic or hypervolemic hyponatremia. J Clin Endocrinol Metab (2006) 1.41
Central pontine myelinolysis. Two cases with associated electrolyte disturbance. Q J Med (1976) 1.40
Nephrogenic syndrome of inappropriate antidiuresis in adults: high phenotypic variability in men and women from a large pedigree. J Am Soc Nephrol (2007) 1.38
The urine/plasma electrolyte ratio: a predictive guide to water restriction. Am J Med Sci (2000) 1.36
Treatment of the syndrome of inappropriate secretion of antidiuretic hormone with furosemide. N Engl J Med (1981) 1.33
Investigation and management of severe hyponatraemia in a hospital setting. Postgrad Med J (2006) 1.31
Consequences of inadequate management of hyponatremia. Am J Nephrol (2005) 1.31
Epidemiology, clinical and economic outcomes of admission hyponatremia among hospitalized patients. Curr Med Res Opin (2008) 1.23
Efficacy and safety of oral conivaptan, a vasopressin-receptor antagonist, evaluated in a randomized, controlled trial in patients with euvolemic or hypervolemic hyponatremia. Am J Med Sci (2009) 1.23
Hyponatremia in a nursing home population. J Am Geriatr Soc (1995) 1.21
Minocycline prevents osmotic demyelination syndrome by inhibiting the activation of microglia. J Am Soc Nephrol (2010) 1.20
Long-term treatment of patients with inappropriate secretion of antidiuretic hormone by the vasopressin receptor antagonist conivaptan, urea, or furosemide. Am J Med (2001) 1.19
Is asymptomatic hyponatremia really asymptomatic? Am J Med (2006) 1.19
Utility and limitations of the traditional diagnostic approach to hyponatremia: a diagnostic study. Am J Med (2010) 1.18
Incidence and pathophysiology of severe hyponatraemia in neurosurgical patients. Postgrad Med J (2009) 1.18
Minocycline protects against neurologic complications of rapid correction of hyponatremia. J Am Soc Nephrol (2010) 1.18
Management of hyponatremic seizures in children with hypertonic saline: a safe and effective strategy. Crit Care Med (1991) 1.15
Hyponatraemia as a risk factor for hospital mortality. QJM (2006) 1.11
Economic impact of hyponatremia in hospitalized patients: a retrospective cohort study. Postgrad Med (2009) 1.10
Causes and management of hyponatremia. Ann Pharmacother (2003) 1.08
The basic and clinical pharmacology of nonpeptide vasopressin receptor antagonists. Annu Rev Pharmacol Toxicol (2001) 1.03
Human cerebral osmolytes during chronic hyponatremia. A proton magnetic resonance spectroscopy study. J Clin Invest (1995) 1.03
Aquaretic effect of lixivaptan, an oral, non-peptide, selective V2 receptor vasopressin antagonist, in New York Heart Association functional class II and III chronic heart failure patients. J Am Coll Cardiol (2006) 1.02
Hypouricemia and hyperuricosuria in Laennec cirrhosis. Arch Intern Med (1974) 1.02
Nonosmolar factors affecting renal water excretion (second of two parts). N Engl J Med (1975) 0.96
Idiopathic syndrome of inappropriate antidiuretic hormone secretion possibly related to advanced age. Ann Intern Med (1983) 0.96
Cerebral salt wasting syndrome in patients with aneurysmal subarachnoid hemorrhage. Neurol Res (2005) 0.94
Cerebral salt wasting syndrome in meningoencephalitis: a case report. J Neurol Neurosurg Psychiatry (2003) 0.94
High incidence of neurologic complications following rapid correction of severe hyponatremia in polydipsic patients. J Clin Psychiatry (1994) 0.93
Plasma demeclocycline levels and nephrotoxicity. Correlation in hyponatremic cirrhotic patients. JAMA (1980) 0.93
Evidence in hyponatremia related to inappropriate secretion of ADH that V1 receptor stimulation contributes to the increase in renal uric acid clearance. J Am Soc Nephrol (1996) 0.90
Sustained low efficiency dialysis in the continuous mode (C-SLED): dialysis efficacy, clinical outcomes, and survival predictors in critically ill cancer patients. Clin J Am Soc Nephrol (2009) 0.89
Downward resetting of the osmotic threshold for thirst in patients with SIADH. Am J Physiol Endocrinol Metab (2004) 0.89
Demeclocycline in the treatment of the syndrome of inappropriate secretion of antidiuretic hormone. Thorax (1979) 0.88
Successful treatment of adult cerebral salt wasting with fludrocortisone. Arch Intern Med (2008) 0.87
Carbamazepine can induce kidney water absorption by increasing aquaporin 2 expression. Nephrol Dial Transplant (2010) 0.85
The Adrogue-Madias formula revisited. Clin J Am Soc Nephrol (2007) 0.84
Chronic idiopathic hyponatremia in older people due to syndrome of inappropriate antidiuretic hormone secretion (SIADH) possibly related to aging. J Am Geriatr Soc (2001) 0.84
Hyponatremia due to reset osmostat in dementia with lewy bodies. J Am Geriatr Soc (2008) 0.84
Carbamazepine diminishes the sensitivity of the plasma arginine vasopressin response to osmotic stimulation. J Clin Endocrinol Metab (1983) 0.81
Role of diuretics, hormonal derangements, and clinical setting of hyponatremia in medical patients. Klin Wochenschr (1988) 0.80
Osmotic myelinolysis syndrome after treatment of severe deamino arginine vasopressin-associated hyponatraemia: pitfalls in emergency medicine. Emerg Med Australas (2007) 0.80
Nephrogenic syndrome of inappropriate antidiuresis. Nephrol Dial Transplant (2010) 0.78
Cervical spinal epidural abscess complicated with cerebral salt wasting. South Med J (2009) 0.76
Managing overly rapid correction of chronic hyponatremia: an ounce of prevention or a pound of cure? J Am Soc Nephrol (2010) 0.76
Tolvaptan, a selective oral vasopressin V2-receptor antagonist, for hyponatremia. N Engl J Med (2006) 10.63
Real-time in vivo imaging of platelets, tissue factor and fibrin during arterial thrombus formation in the mouse. Nat Med (2002) 4.54
Accumulation of tissue factor into developing thrombi in vivo is dependent upon microparticle P-selectin glycoprotein ligand 1 and platelet P-selectin. J Exp Med (2003) 3.61
Aspirin versus low-molecular-weight heparin for extended venous thromboembolism prophylaxis after total hip arthroplasty: a randomized trial. Ann Intern Med (2013) 3.40
Strategies to prevent central line-associated bloodstream infections in acute care hospitals. Infect Control Hosp Epidemiol (2008) 3.13
Phase I trial of intravenous administration of PV701, an oncolytic virus, in patients with advanced solid cancers. J Clin Oncol (2002) 2.41
A compendium of strategies to prevent healthcare-associated infections in acute care hospitals. Infect Control Hosp Epidemiol (2008) 2.32
Strategies to prevent catheter-associated urinary tract infections in acute care hospitals. Infect Control Hosp Epidemiol (2008) 2.30
Impact of initial antibiotic choice on clinical outcomes in community-acquired pneumonia: analysis of a hospital claims-made database. Chest (2003) 2.25
Strategies to prevent surgical site infections in acute care hospitals. Infect Control Hosp Epidemiol (2008) 2.22
Selective D-dimer testing for diagnosis of a first suspected episode of deep venous thrombosis: a randomized trial. Ann Intern Med (2013) 2.09
Unraveling the structure of DNA during overstretching by using multicolor, single-molecule fluorescence imaging. Proc Natl Acad Sci U S A (2009) 1.95
Strategies to prevent clostridium difficile infections in acute care hospitals. Infect Control Hosp Epidemiol (2008) 1.84
Strategies to prevent ventilator-associated pneumonia in acute care hospitals. Infect Control Hosp Epidemiol (2008) 1.81
Prospects for urinary proteomics: exosomes as a source of urinary biomarkers. Nephrology (Carlton) (2005) 1.77
Role of humoral and cell-mediated immunity in protection from influenza disease after immunization of healthy elderly. Exp Gerontol (2002) 1.74
Dry cough in a CAPD patient. Nephrol Dial Transplant (2003) 1.68
Therapy of hyponatremia in cirrhosis with a vasopressin receptor antagonist: a randomized double-blind multicenter trial. Gastroenterology (2003) 1.66
Strategies to prevent transmission of methicillin-resistant Staphylococcus aureus in acute care hospitals. Infect Control Hosp Epidemiol (2008) 1.66
Baseline blood flow and bradykinin-induced vasodilator responses in the human forearm are insensitive to the cytochrome P450 2C9 (CYP2C9) inhibitor sulphaphenazole. Clin Sci (Lond) (2003) 1.49
Successful long-term treatment of hyponatremia in syndrome of inappropriate antidiuretic hormone secretion with satavaptan (SR121463B), an orally active nonpeptide vasopressin V2-receptor antagonist. Clin J Am Soc Nephrol (2006) 1.32
Rosiglitazone improves glomerular hyperfiltration, renal endothelial dysfunction, and microalbuminuria of incipient diabetic nephropathy in patients. Diabetes (2005) 1.25
PPARgamma-agonist rosiglitazone increases number and migratory activity of cultured endothelial progenitor cells. Atherosclerosis (2005) 1.25
In type 2 diabetes, rosiglitazone therapy for insulin resistance ameliorates endothelial dysfunction independent of glucose control. Diabetes Care (2004) 1.17
Revealing the competition between peeled ssDNA, melting bubbles, and S-DNA during DNA overstretching using fluorescence microscopy. Proc Natl Acad Sci U S A (2013) 1.14
The influence of uraemia and haemodialysis on neutrophil phagocytosis and antimicrobial killing. Nephrol Dial Transplant (2003) 1.10
Increased total number but impaired migratory activity and adhesion of endothelial progenitor cells in patients on long-term hemodialysis. Am J Kidney Dis (2004) 1.09
Thiazides: do they kill? Nephrol Dial Transplant (2005) 1.01
Rho kinase contributes to basal vascular tone in humans: role of endothelium-derived nitric oxide. Am J Physiol Heart Circ Physiol (2007) 0.95
Reduced agonist-induced endothelium-dependent vasodilation in uremia is attributable to an impairment of vascular nitric oxide. J Am Soc Nephrol (2005) 0.93
Visualizing cytoplasmic flow during single-cell wound healing in Stentor coeruleus. J Vis Exp (2013) 0.92
Hyperkalaemia: again. Nephrol Dial Transplant (2004) 0.92
Pharmacokinetics of gemcitabine in a patient with end-stage renal disease: effective clearance of its main metabolite by standard hemodialysis treatment. Cancer Chemother Pharmacol (2003) 0.88
A general and efficient method for the formylation of aryl and heteroaryl bromides. Angew Chem Int Ed Engl (2005) 0.86
Gitelman syndrome: when will it turn into Gitelman disease? Pediatr Nephrol (2003) 0.84
Observation of the critical regime near Anderson localization of light. Phys Rev Lett (2006) 0.84
Successful treatment due to vacuum seal technique of a severe Scedosporium apiospermum skin infection in a renal transplant recipient. Nephrol Dial Transplant (2004) 0.84
Effects of homocysteine on the levels of caveolin-1 and eNOS in caveolae of human coronary artery endothelial cells. Atherosclerosis (2006) 0.83
Vasopressin antagonists as aquaretic agents for the treatment of hyponatremia. Am J Med (2006) 0.83
Endothelial progenitor cells in chronic renal insufficiency. Kidney Blood Press Res (2006) 0.83
A toolbox for generating single-stranded DNA in optical tweezers experiments. Biopolymers (2013) 0.82
Vaptans and the treatment of water-retaining disorders. Semin Nephrol (2006) 0.81
Kidney transplantation improves endothelium-dependent vasodilation in patients with endstage renal disease. Transplantation (2003) 0.80
Enhanced external counterpulsation: a new technique to augment renal function in liver cirrhosis. Nephrol Dial Transplant (2005) 0.80
Resumption of peritoneal dialysis after transcutaneous treatment of a peritoneal leakage using fibrin glue. Nephrol Dial Transplant (2006) 0.80
Nitric oxide- and EDHF-mediated arteriolar tone in uremia is unaffected by selective inhibition of vascular cytochrome P450 2C9. Kidney Int (2005) 0.79
Amino acid-based peritoneal dialysis solution stimulates mesothelial nitric oxide production. Perit Dial Int (2004) 0.79
The vaptans ante portas: a status report. Nephrol Dial Transplant (2009) 0.78
The vaptans: just landed. But how was the trip? Nephrol Dial Transplant (2010) 0.78
PPAR agonists in diabetic nephropathy. Nephrol Dial Transplant (2007) 0.77
Biophysics of DNA-ligand interactions resolved by force. Comment on "Biophysical characterization of DNA binding from single molecule force measurements" by K.R. Chaurasiya et al. Phys Life Rev (2010) 0.77
Proximal RTA: Are all the charts completed yet? Nephrol Dial Transplant (2008) 0.76
Hyponatremia now--a goldmine or a dead end? Adv Clin Exp Med (2013) 0.76
Rescue of protein mutants: why? Nephrol Dial Transplant (2004) 0.75
Functional Gitelman syndrome? Am J Kidney Dis (2004) 0.75
[Causes, diagnosis and differential diagnosis of hyponatremia]. Dtsch Med Wochenschr (2016) 0.75
Reduced endothelin-1- and nitric oxide-mediated arteriolar tone in hypertensive renal transplant recipients. Kidney Int (2004) 0.75
Renal transport proteins in excreted urine: gold mine or gold dust? Kidney Int (2004) 0.75
The vascular endothelin system is not overactive in normotensive hemodialysis patients. Kidney Int (2002) 0.75
An old patient with end stage renal disease and sudden onset of confusion and lethargy. Nephrol Dial Transplant (2006) 0.75
A young patient with end-stage renal disease, dyspnoea, weakness, peripheral neuropathy and an unsuspected underlying disease. Nephrol Dial Transplant (2003) 0.75
Exploring a new structure family: alkali borosulfates Na5[B(SO4)4], A3[B(SO4)3] (A = K, Rb), Li[B(SO4)2], and Li[B(S2O7)2]. Inorg Chem (2013) 0.75